PRAX peer analysis
Praxis Precision Medicines (PRAX) against its competitors: price, today's move, 1-year return and market value side by side.
PRAX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | $21.23 | -0.05% | -5.73% | $3.66B |
| ADXN Addex Therapeutics | $2.90 | -4.70% | – | – |
| AVXL Anavex Life Sciences | $1.15 | 3.60% | -84.54% | $102.89M |
| AXSM Axsome Therapeutics | $132.37 | 1.98% | -1.43% | $6.83B |
| DNLI Denali Therapeutics | $20.16 | 2.23% | 34.59% | $3.16B |
| NBIX Neurocrine Biosciences | $164.63 | 3.05% | 6.13% | $16.17B |
| NMRA Neumora Therapeutics | $0.49 | -13.96% | -81.41% | – |
| RAPP Rapport Therapeutics | $24.44 | 3.04% | -8.44% | – |
| SUPN Supernus Pharmaceuticals | $26.16 | -2.17% | -52.82% | $1.56B |
| XENE Xenon Pharmaceuticals | $39.39 | 4.54% | -1.06% | $3.65B |
| PRAX Praxis Precision Medicines | $279.00 | 6.25% | 62.96% | – |
- PRAX's peers: ACAD (Acadia Pharmaceuticals), ADXN (Addex Therapeutics), AVXL (Anavex Life Sciences), AXSM (Axsome Therapeutics), DNLI (Denali Therapeutics), NBIX (Neurocrine Biosciences), NMRA (Neumora Therapeutics), RAPP (Rapport Therapeutics).
Updated 2026-11-07 11:55 UTC